Project Persist: mHealth for Cancer Survivorship

NACompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

July 27, 2020

Primary Completion Date

October 19, 2023

Study Completion Date

October 19, 2023

Conditions
Symptom ManagementReduce Treatment Non-adherence
Interventions
BEHAVIORAL

Assessment only group

Individuals randomized to this group will receive radiation therapy as usual plus baseline, follow-up, and EMA assessments.

BEHAVIORAL

Intervention group

Individuals randomized to the intervention group will complete the same measures (in person and daily EMAs) as the assessment only group, but will additionally receive messaging that is tailored to patient responses on EMAs.

Trial Locations (1)

73104

Stephenson Cancer Center, Oklahoma City

All Listed Sponsors
lead

University of Oklahoma

OTHER

NCT04126642 - Project Persist: mHealth for Cancer Survivorship | Biotech Hunter | Biotech Hunter